VitalTrace has had the pleasure of participating in iPREP WA's Industry and PhD Research and Engagement Program. We were fortunate to work with our very own “Dream Team”; Alvin Lee, Saman Akbar Zadeh and Georgios Mavropalias, bringing their expertise in signal processing, data science and biomedical science respectively.
No items found.
No items found.
Childbirth monitoring technology has barely changed since the 1960s
Thank you to the University of Western Australia for a wonderful video featuring our co-founders, Dr. Arjun Kaushik and Dr Michael Challenor, PhD.
November 4, 2020
•
3 min read
No items found.
VitalTrace awarded $656,666 for the Clinical translation of a novel continuous lactate biosensor for fetal monitoring
VitalTrace was founded to improve the safety for mothers and babies during childbirth - babies being some of our youngest and most vulnerable patients.
September 30, 2023
•
3 min read
VitalTrace was founded to improve the safety for mothers and babies during childbirth - babies being some of our youngest and most vulnerable patients. We are passionate about eliminating the unnecessary health, psychological and economic burdens from inaccurate childbirth monitoring.
This project will progress development and clinical testing of a continuous lactate sensor, with the potential to revolutionise fetal monitoring during labour globally.
Current fetal monitoring technology is inaccurate, subjective and creates difficulties for clinicians leading to complications for mothers and babies. VitalTrace is developing DelivAssureTM, a breakthrough technology designed to continuously monitor clinically validated biomarkers to reduce fetal morbidities and wirelessly transmit readings to an associated display monitor.
The funding awarded through the Clinical Translation and Commercialisation Medtech grant, will help design and run VitalTrace's first clinical trial, testing DelivAssureTM, a novel continuous lactate biosensor, which has already received Breakthrough Device designation from the US FDA.
No items found.
VitalTrace receives government backing for local manufacturing
VitalTrace is proud to announce it has received support from the McGowan government, Roger Cook and Medical Technology and Pharmaceutical (MTP) Connect under the WA Life Sciences Innovation Hub Manufacturing Voucher Program.
November 4, 2021
•
3 min read
VitalTrace is proud to announce it has received support from the McGowan government, Roger Cook and Medical Technology and Pharmaceutical (MTP) Connect under the WA Life Sciences Innovation Hub Manufacturing Voucher Program.
MTPConnect Managing Director and CEO, Dr Dan Grant, said, “Manufacturing medical products is a national priority so we’re supporting these promising projects to develop their medical devices and diagnostics.”
The MTP initiative, driven by Tracey Wilkinson and Kevin Pfleger, aims to accelerate the development and manufacturing of medical technology and pharmaceutical products in WA, such as medical devices, diagnostics, biologics and pharmaceuticals. The program is currently co-funded through the McGowan Government's New Industries Fund, industry growth centre MTPConnect and The University of Western Australia.
VitalTrace is honoured to be one of five WA-based companies under the scheme to been awarded a total of $450,000 to accelerate innovation projects requiring advanced manufacturing capabilities.
VitalTrace’s Chief Executive Officer said, “We are so fortunate to be supported by the McGowan Government through MTPConnect. This will not only bolster our path to market, but also bring new opportunities for Western Australia.”
This wonderful news adds to recent announcement of a new fund of approximately $40 million of ongoing support made towards health and medical research, innovation and commercialisation in Western Australia by Roger Cook.